Steroid treatment after stent placement for unruptured brain aneurysm
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether adding a steroid called methylprednisolone during a procedure to place a stent for an unruptured brain aneurysm can reduce side effects and improve recovery. It's a phase 4 study, meaning the drug is already approved for other uses, and researchers are checking if it works well for this specific situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have an unruptured brain aneurysm (a bulge in a blood vessel that hasn't burst) that is between 3 and 25 mm in size.
- You are scheduled to have a flow diverter stent (a small tube placed in the artery to redirect blood flow) placed.
- You are willing to attend follow-up visits as required by the study.
- You are not pregnant, planning to become pregnant, or breastfeeding.
- You have not had a stroke in the past 30 days and do not have other serious health conditions that would make this treatment unsafe (like active infections, severe heart or kidney disease, or certain digestive problems).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking atorvastatin before a flow diverter procedure can prevent strokes or other brain events in people with unruptured brain aneurysms. It may help reduce complications from the treatment.
This trial tests a flow-diverter stent (a small mesh tube) to treat brain aneurysms that are hard to close with standard methods. It may help if you have a wide-neck or other complex aneurysm that hasn't burst.
This trial tests whether adding a steroid (methylprednisolone) to the standard clot-removal procedure can improve recovery in people with a severe, large stroke. It aims to reduce brain swelling and improve outcomes after the procedure.
This trial tests whether adding a steroid medicine (methylprednisolone) to the standard procedure to remove a blood clot (thrombectomy) can improve recovery in people with large, severe strokes. The study aims to see if the steroid helps reduce brain swelling and improves outcomes.
This study compares two ways to treat a type of brain aneurysm (a weak spot in a blood vessel) that has not burst. It looks at early problems after using a flow diverter or stent-assisted coiling, to see which might be safer or more effective.
This trial tests whether injecting a steroid (methylprednisolone) directly into brain blood vessels after removing a stroke clot helps reduce brain swelling and improve recovery. You would be eligible if you had a large clot stroke in the front part of your brain that was successfully removed within the past 24 hours.
Hear when a new Cerebrovascular Event trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.